RxDoctor Payments Data

Brian de Beaubien, MD

Adult Reconstructive Orthopaedic Surgery · Saginaw, MINPI 1043241573

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $98,000 of the $117,365 with a category attached, or 83.5%. Microport Orthopedics Inc accounts for 85.2% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2023 at $68,353 and has fallen 99.5% since, to $349 in 2025.

$117,365in general payments, 2019–2025

Across 27 payments — averaging $4346.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Microport Orthopedics Inc$100K
  • Linkbio Corp$17K
  • Next Science LLC$312
  • Davol Inc.$148
  • Zimmer Biomet$82
  • Johnson & Johnson$41
  • plus $103 from 5 others
$430,637in research payments, 2019–2025

Across 21 payments — averaging $20,507 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Microport Orthopedics Inc$431K

What the payments were for

  • Royalty or licence$98,00084%
  • Consulting fees$9,5008%
  • Travel & lodging$8,6287%
  • Food & beverage$1,2361%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$117,365 in reported general payments places this provider in the 80th percentile of 35 adult reconstructive orthopaedic surgery providers in Michigan.

See all adult reconstructive orthopaedic surgery providers in Michigan

Medicare billing

Part B allowed, 2024
$113,288
Medicare patients
172
Services billed
2,384

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib72$1,231
Cephalexin30$387
Doxycycline Hyclate24$334
Amoxicillin109$168
Mupirocin14$63
Clindamycin Hcl39$55

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Saginaw

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →